EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amelioration of signaling deficits underlying metabolic shortfall in TREM2 R47H human iPSC ‐derived microglia

Foteini Vasilopoulou iD, Thomas M Piers, Jingzhang Wei, John Hardy, Jennifer M Pocock iD

The FEBS Journal · 2025

DOI: 10.1111/febs.17353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2025. Verfasst von Foteini Vasilopoulou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, UK. Hauptthemen laut MEDLINE: Microglia, Receptors, Immunologic, Induced Pluripotent Stem Cells, Membrane Glycoproteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Medical Research Council Core Funding to the MRC LMCB and Dementia Platform UK, Innovative Medicines Initiative 2 Joint Undertaking Under Grant Agreement.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The microglial triggering receptor expressed on myeloid cells 2 (TREM2) is required for diverse microglia responses in neurodegeneration, including immunometabolic plasticity, phagocytosis, and survival. We previously identified that patient iPSC‐derived microglia (iPS‐Mg) harboring the Alzheimer's disease (AD) TREM2 R47H hypomorph display several functional deficits linked to metabolism. To investigate whether these deficits are associated with disruptions in metabolite signaling, we generated common variant, TREM2 R47H and TREM2 −/− variant human iPS‐Mg. We assessed the ability of supplementation with citrate or succinate, key metabolites and cell cycle breaking points upon microglia activation, to overcome these functional deficits with potential impact on neurons. Succinate supplementation was more effective than citrate at overcoming mitochondrial deficits in OXPHOS and did not promote a glycolytic switch. Citrate enhanced the lipid content of TREM2 R47H iPS‐Mg and was more effective at overcoming Αβ phagocytic deficits, whereas succinate increased lipid content and phagocytic capacity in TREM2 −/− iPS‐Mg. Microglia cytokine secretion upon pro‐inflammatory activation was moderately affected by citrate or succinate showing a condition‐dependent increasing trend. Neither metabolite altered basal levels of soluble TREM2 shedding. In addition, neither citrate nor succinate enhanced glycolysis; instead, drove their effects through oxidative phosphorylation. IPS‐neurons exposed to conditioned medium from TREM2 variant iPS‐Mg showed changes in oxidative phosphorylation, which could be ameliorated when iPS‐Mg were first treated with citrate or succinate. Our data point to discrete pathway linkage between microglial metabolism and functional outcomes with implications for AD pathogenesis and treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaReceptors, ImmunologicInduced Pluripotent Stem CellsMembrane GlycoproteinsAlzheimer DiseaseHumansSignal TransductionPhagocytosisSuccinic AcidCitric AcidMitochondriaGlycolysisOxidative Phosphorylation

Stichwörter der Autor:innen

Alzheimer's diseaseR47H TREM2 variantTCA‐metaboliteshuman microgliametabolismneurodegeneration

Substanzen

Receptors, ImmunologicTREM2 protein, humanMembrane GlycoproteinsSuccinic AcidCitric Acid

Autor:innen und Institutionen

  • Department of Neuroinflammation, UCL Queen Square Institute of Neurology, University College London, UK.
  • Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
  • UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, UK.
  • Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, UK.
  • NIHR University College London Hospitals Biomedical Research Centre and Institute for Advanced Study, The Hong Kong University of Science and Technology, China.

ORCID-Profile: Foteini Vasilopoulou, Jennifer M Pocock

Förderung

  • Medical Research Council
  • Medical Research Council Core Funding to the MRC LMCB and Dementia Platform UK
  • Innovative Medicines Initiative 2 Joint Undertaking Under Grant Agreement

Zitieren

APA

Vasilopoulou, F., Piers, T. M., Wei, J., Hardy, J., & Pocock, J. M. (2025). Amelioration of signaling deficits underlying metabolic shortfall in TREM2 R47H human iPSC ‐derived microglia. The FEBS Journal. https://doi.org/10.1111/febs.17353

Vancouver

Vasilopoulou F, Piers TM, Wei J, Hardy J, Pocock JM. Amelioration of signaling deficits underlying metabolic shortfall in TREM2 R47H human iPSC ‐derived microglia. The FEBS Journal. 2025. doi:10.1111/febs.17353

BibTeX
@article{Vasilopoulou2025,
  author = {Vasilopoulou, Foteini and Piers, Thomas M and Wei, Jingzhang and Hardy, John and Pocock, Jennifer M},
  title = {Amelioration of signaling deficits underlying metabolic shortfall in TREM2 R47H human iPSC ‐derived microglia},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.17353}
}
Kostenlos starten →